Health Technology · Pharmaceuticals: Major · NSE: SOLARA · data 2026-10-09

Solara Active Pharma Sciences Ltd.

Health check: Weak (2.9/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹644.35

Market cap

₹3,149 cr

P/E

—

P/B

—

ROE

-0.6%

ROCE

5.9%

Debt / equity

0.55

Dividend yield

0.00%

1-year return

7.4%

52-week high

₹774

52-week low

₹422

Operating margin

6.2%

Growth

Revenue (last 12 months)	₹1,431 cr
Net profit (last 12 months)	₹-2 cr
Sales growth, 3 years (yearly)	-1.6%
Profit growth, 3 years (yearly)	—

Chart patterns

Double top — breakdown (key level ₹669)

Similar companies

Aarti Drugs Limited (AARTIDRUGS) · Unichem Laboratories Limited (UNICHEMLAB) · Kwality Pharmaceuticals Ltd (KPL) · Ind-Swift Laboratories Ltd. (INDSWFTLAB) · Shukra Pharmaceuticals Ltd. (SHUKRAPHAR)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SOLARA in NSE Scanner →